Radius Health, Inc. announced that James G. Chopas, age 54, was appointed as the Principal Financial Officer, Principal Accounting Officer and Treasurer of company. Mr. Chopas has served as the company’s corporate controller since he joined the company in October 2018. In that role, he has management and oversight responsibility for the Company’s finance and accounting functions and works closely with all of the Company’s business lines as well as the Company’s external auditors. Prior to joining Radius, from September 2016 to October 2018, Mr. Chopas was a consultant for Danforth Advisors, a strategic consulting firm for life sciences companies and the healthcare technology industry. Before Danforth, he served as Vice President and Chief Financial Officer of KBI Biopharma, Inc., a global contract development and manufacturing organization. Previously, he held several senior management roles for certain ThermoFisher Scientific’s portfolio companies and Parexel International. Mr. Chopas succeeds Dan Dolan as Principal Financial Officer, Principal Accounting Officer and Treasurer of the Company. Mr. Dolan is expected to remain in his position as Vice President, Financial Planning and Analysis of the Company through January 15, 2020. Also effective December 15, 2020, Dr. Bruce Mitlak was appointed as the Company’s Chief Medical Officer. Dr. Mitlak succeeds Dr. Charles Morris as Chief Medical Officer of the Company. In connection with his departure on December 15, 2020, Dr. Morris is entitled to receive (a) accelerated vesting of 17,361 unvested restricted stock units previously awarded to Dr. Morris, (b) a lump sum payment equal to the pay he would have received between December 15, 2020 and March 15, 2021 plus 100% of his 2020 target bonus, (c) a lump sum severance payment in an amount equal to nine months of his base salary and (d) a lump sum payment equal to the COBRA premiums necessary to continue his and his dependents’ health insurance coverage for a period of nine months, in exchange for executing and delivering to the Company a General Release of Claims. Separately, the Company entered into a Consulting Agreement with Dr. Morris, effective December 16, 2020 (the “Consulting Agreement”), pursuant to which Dr. Morris agreed to provide support for Radius’ ongoing activities. The Consulting Agreement terminates on March 31, 2021 and provides for aggregate payments to Dr. Morris of $150,000 to be paid in three equal monthly installments beginning January 29, 2021.